Chondroitin use confirmed in Cochrane Review

knee pain
Carl Gibson, chief executive of Complementary Medicines Australia has welcomed the results of a Cochrane Review of chondroitin sulfate that confirm the efficacy and safety of this supplement in the treatment of osteoarthritis. This follows the recent publication of the MOVES study, which showed equivalent benefits of taking glucosamine and chondroitin for OA of the

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Patients dying in cancer drugs wait: MA
Next Juvenile arthritis as common as juvenile diabetes